Kinetic Concepts plans to buy back $112 million of bonds due 2019 when it has excess cash provided that the debt trades at an attractive price, said Nathan Speicher, the issuer’s vice president of investor relations and treasury. Click HERE for more.
Contribution by Phil Birch, Ph.D., Senior Vice President, Global Strategic Marketing at Aptiv Solutions Adaptive designs can bring substantial benefits to sponsor companies if adopted broadly at the portfolio level. For instance, available data indicate that futility stopping in Phase II and Phase III can save mid-size biopharma companies between $5 million and $10 [...]
Download our new Real Estate Supplement here.
Holdings of U.S. exchange-traded notes have climbed by about a third this year while sales of unlisted structured securities stagnate, as investors prefer their greater liquidity and access to dividends. Issuance of structured notes fell to $28.5 billion this year through Sept. 20, down less than 1 percent from the same period of 2012, according [...]
The Ohio Police & Fire Pension Fund is boosting its holdings of high-yield debt, including floating-rate bank loans, while reducing equities to limit volatility. Click HERE for more.
by Andrew Berens, Grace Guo, Bloomberg Industries AbbVie’s supplemental Biologics License Application (sBLA) to expand Humira’s existing approval for ankylosing spondylitis to include the treatment of non-radiographic axial spondyloarthritis has an estimated PDUFA date of Sept. 29. Read more>>>
Sales of structured notes tied to interest rate moves are surpassing those linked to credit risk for the first time in almost two years as investors seek to profit from rising rates. Deutsche Bank AG and DZ Bank AG led sales of $4.74 billion of rate-tied notes in the third quarter through Sept. 18, exceeding [...]
Central European Media Enterprises may skip a chance to refinance 273 million euros ($365 million) of 11.625 percent bonds due September 2016 that lost make-whole protection this week after a ratings cut by Moody’s. Click HERE for more.
Richard Schimel, co-founder of Diamondback Capital Management LLC, will start a new hedge-fund firm in the fourth quarter to trade global stocks, according to a letter sent to potential investors. Click here to continue reading.
By Sam Fazeli, Bloomberg Industries Boehringer Ingelheim may join Novartis in challenging GlaxoSmithKline’s dominance in the treatment of respiratory diseases with new safety data on its Respimat device. While the data may not stave off generic competition for one of its top-selling drugs, Spiriva, it may allow Boehringer to develop a competitive combination therapy. [...]